New Zealand markets open in 3 hours 47 minutes
  • NZX 50

    11,434.82
    -83.50 (-0.72%)
     
  • NZD/USD

    0.5629
    -0.0117 (-2.03%)
     
  • ALL ORDS

    6,667.50
    -121.20 (-1.79%)
     
  • OIL

    77.23
    -1.51 (-1.92%)
     
  • GOLD

    1,636.80
    -18.80 (-1.14%)
     

Here's How This Beaten-Down Stock Could 10X by 2024

·4-min read

On that note, Ocugen (NASDAQ: OCGN) stock is down by more than 65% this year as the small biotech has struggled to commercialize a coronavirus vaccine. To remedy that issue, it's licensing a coronavirus vaccine called Covaxin from Bharat Biotech, an Indian pharmaceutical business. While it's already approved in India, the chances of Ocugen successfully commercializing Covaxin in the U.S. remain a question mark.